REQUEST A DEMO
Total
USD $0.00
Search more companies

Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock (Jaber Ebne Hayyan) (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock Profile Updated: March 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock (Jaber Ebne Hayyan) is based in Iran. The head office is in Tehran. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was established on April 15, 1961. Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock (Jaber Ebne Hayyan) currently employs 501 (2025) people. From the latest financial highlights, Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock (Jaber Ebne Hayyan) reported a net sales revenue increase of 9.56% in 2025. Over the same period, its total assets grew by 7.69%. In 2025, Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock (Jaber Ebne Hayyan)’s net profit margin decreased by 31.89%.

Headquarters
Km 5 Karaj Special Road, P.O.Box: 13185-1739
Tehran; Tehran; Postal Code: 13988-34511

Contact Details: Purchase the Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock (Jaber Ebne Hayyan) report to view the information.

Website: http://www.jaber-pharma.com

Basic Information
Total Employees:
Purchase the Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock (Jaber Ebne Hayyan) report to view the information.
Outstanding Shares:
Purchase the Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock (Jaber Ebne Hayyan) report to view the information.
Financial Auditors:
Purchase the Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock (Jaber Ebne Hayyan) report to view the information.
Incorporation Date:
April 15, 1961
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
60.85%
Purchase this report to view the information.
16.58%
Purchase this report to view the information.
0.6%
Purchase this report to view the information.
0.46%
Purchase this report to view the information.
0.12%
Subsidiaries
Pakhsh Razi Company Public Joint Stock
25.16%
Shahid Ghazi Pharmaceutical Company Public Joint Stock
7%
Ramopharmin Company Private Jo
Company Performance
Financial values in the chart are available after Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock (Jaber Ebne Hayyan) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
9.56%
Total Operating Revenue
18.48%
Operating Profit
101.51%
EBITDA
101.05%
Net Profit/Loss for the Period
-51.9%
Total Assets
7.69%
Total Equity
2.52%
Operating Profit Margin
11.52%
Net Profit Margin
-31.89%
Return on Equity (ROE)
-24.02%
Debt / Equity
76%
Quick Ratio
-256.7%
Cash Ratio
-0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?